financetom
Business
financetom
/
Business
/
*-- Lithium Americas (Argentina) Corp. Brief: Q1 Loss per share -Basic US$(0.06 )
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
*-- Lithium Americas (Argentina) Corp. Brief: Q1 Loss per share -Basic US$(0.06 )
May 13, 2024 2:44 PM
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sunoco Prices $1.5 Billion Debt Offering
Sunoco Prices $1.5 Billion Debt Offering
Apr 16, 2024
05:54 PM EDT, 04/16/2024 (MT Newswires) -- Sunoco ( SUN ) said late Tuesday it priced a $1.50 billion private offering of senior notes in two tranches at 100% of face value. The offering comprises $750 million of 7% notes due 2029 and $750 million of 7.25% notes due 2032. The company expects the offering to close April 30 and...
Chevron arm launches $500 million fund to invest in low carbon technologies
Chevron arm launches $500 million fund to invest in low carbon technologies
Apr 16, 2024
April 16 (Reuters) - Chevron's ( CVX ) venture capital arm launched on Tuesday its third fund to invest in renewable energy technologies with a $500 million commitment, as oil majors look to diversify their business in the face of pressure to reduce their emissions. Like the previous two funds, the Future Energy Fund III will focus on innovations in...
Olympics-Team Canada goes for cool factor in Paris Games kit
Olympics-Team Canada goes for cool factor in Paris Games kit
Apr 16, 2024
TORONTO, April 16 (Reuters) - Team Canada unveiled the kit athletes will wear at this year's Paris Olympics on Tuesday, a high-tech design focusing on thermal comfort while paying homage to the country's indigenous heritage. In designing their first Summer Games collection, Lululemon said it leaned heavily on product testing and feedback from 19 Canadian Olympic and Paralympic athletes across...
Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease
Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease
Apr 16, 2024
05:56 PM EDT, 04/16/2024 (MT Newswires) -- Amgen ( AMGN ) said late Tuesday it is planning for the phase 3 trial of tezepelumab in chronic obstructive pulmonary disease, encouraged by the results of phase 2a proof-of-concept study. The company said the phase 2a study investigated tezepelumab in moderate to very severe COPD patients. Overall, tezepelumab numerically reduced the annualized...
Copyright 2023-2026 - www.financetom.com All Rights Reserved